Matches in Nanopublications for { ?s ?p ?o <http://bio2rdf.org/drugbank_resource:DB00906_DB01601_nanopub.RAfB2HcJ-ekLz-i2F1MrwjhSDn7bzkeKEzppjV9Q-4hDk#assertion>. }
Showing items 1 to 6 of
6
with 100 items per page.
- drugbank_resource:DB00906_DB01601 type drugbank_vocabulary:Drug-Drug-Interaction assertion.
- drugbank_resource:DB00906_DB01601 label "DDI between Tiagabine and Lopinavir - The strong CYP3A4 inhibitor, Lopinavir, may decrease the metabolism and clearance of Tiagabine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Tiagabine if Lopinavir is initiated, discontinued or dose changed. [drugbank_resource:DB00906_DB01601]" assertion.
- drugbank_resource:DB00906_DB01601 identifier "drugbank_resource:DB00906_DB01601" assertion.
- drugbank_resource:DB00906_DB01601 title "DDI between Tiagabine and Lopinavir - The strong CYP3A4 inhibitor, Lopinavir, may decrease the metabolism and clearance of Tiagabine, a CYP3A4 substrate. Consider alternate therapy or monitor for changes in the therapeutic/adverse effects of Tiagabine if Lopinavir is initiated, discontinued or dose changed." assertion.
- drugbank:DB01601 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00906_DB01601 assertion.
- drugbank:DB00906 drugbank_vocabulary:ddi-interactor-in drugbank_resource:DB00906_DB01601 assertion.